Montag & Associates’s Tenaris TS Stock Holding History

Montag & Associates’s Portfolio TS Stock Details TS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15	Closed	-$537	–	1155
2025 Q3	$537	Buy	+15	New	+$545	﹤0.01%	1079
2017 Q3	–	Sell	-17,410	Closed	-$542K	–	256
2017 Q2	$542K	Sell	17,410 -95,746	-85%	-$3.02M	0.06%	180
2017 Q1	$3.86M	Buy	+113,156	New	+$3.85M	0.43%	74

Other funds holding TS

WGI

Westwood Global Investments Boston, Massachusetts $2.68B AUM 76.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Montag & Associates's TS Position: Q4 2025 in Review

Montag & Associates sold out of Tenaris (TS) in Q4 2025, closing a stake of 15 shares — an estimated $537 sold.

Montag & Associates first reported a position in TS in Q1 2017 and held it in 3 quarters. The position peaked at $3.86M in Q1 2017. 229 funds tracked by Wall St. Rank hold TS as of Q4 2025.

Montag & Associates reported no remaining Tenaris position as of Q4 2025 after selling out during the quarter.
Montag & Associates sold 15 Tenaris shares in Q4 2025, an estimated $537.
Montag & Associates first reported a position in Tenaris in Q1 2017 and held it in 3 quarters.
Montag & Associates's Tenaris position peaked at $3.86M in Q1 2017.
229 funds tracked by Wall St. Rank held Tenaris as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.